YA banner2

ColNetworkBig 

 

1. Cognitive markers to detect decline in preclinical AD. Dr Martin Vyhnalek and Hana Markova. Memory Disorders Clinic, Department of Neurology, Motol University Hospital, Prague.

2. Exploring the preclinical stages of AD. Prof. David Loewenstein, PhD, ABPP, Department of Psychiatry and Behavioral Sciences, Miller School of Medicine, University of Miami.

3. Exploring novel cognitive tests that are associated with cognitive changes in preclinical stages of Alzheimer’s disease. Massachusetts General Hospital, Boston, MA. Prof. Dorene Rentz and Dr Yakeel Quiroz.

4. Tackling cultural barriers in cognitive assessment and early detection of dementias. University of São Paulo and the University of Edinburgh. Prof. Mônica Yassuda, http://www.fapesp.br/en/8730 

5. Short-term memory binding: a preclinical cognitive marker for AD. Dr David Huepe and Dr Andrea Slachevsky University Diego Portales, Santiago de Chile. (http://www.nucleoneurociencias.udp.cl/index.php/nufin-forma-parte-de-proyecto-de-investigacion-internacional-uk-latin-america-brain-connectivity-research-network-ul-bcrn/

6. A default mode network approach to brain disconnection as the underlying mechanism of working memory binding deficits in preclinical Alzheimer’s Disease. Details of a Collaborator: Dr. Agustin Ibañez, Instutue for Cognitive Neurology (INECO), Buenos Aires, Argentina.

7. Evaluation of the sensitivity and specificity of different memory tests for Alzheimer's disease. Professor Stefano Cappa, Fondazione Centro San Raffaele del Monte Tabor, State University of Milan. Professor Sergio Della Sala and Professor Robert Logie, University of Edinburgh

8. Working memory binding in Pre-MCI in SMI/memory complainers or relatives of late onset (sporadic) AD patients. Prof. Dr. Michael Wagner, Department of Psychiatry, University of Bonn.

9. Working memory binding and neuroimaging biomarkers in the early detection AD-related changes. Professor Yaakov Stern, Department of Neurology and Taub Institute for Research on Alzheimer's Disease, Columbia University.

10. Default Mode Network in healthy ageing and MCI. Dr Agustín Ibañez and Professor Facundo Manes, Laboratory of Experimental Psychology & Neuroscience Institute of Cognitive Neurology (INECO) & CONICET, Buenos Aires, Argentina.

11. Working Memory Binding Dysfunction in APOE e4 carriers. Professor Richard J. Caselli, M.D., Professor of Neurology, Clinical Core Director, Arizona Alzheimer’s Disease.

12. Relationship between white matter and cognitive function across the adult lifespan. Dr Andy Simmons, Dr Mitul Mehta, Dr Flavio Dell’ Acqua, Dr Marco Catani, Dr Michel Thiebaut de Schotten and Anoushka Leslie. Centre for Neuroimaging Sciences, Institute of Psychiatry, King’s College of London.

13. Correlations between working memory binding and neuroimaging biomarkers (MTL) in healthy ageing and amnestic MCI. David A. Wolk, MD, Assistant Professor, Department of Neurology, University of Pennsylvania.

14. Short-term memory binding: validity as a cognitive biomarker for Alzheimer's disease across cultures and nations. Professor Sara F Guinea. Department of Basic Psychology Faculty Complutense University of Madrid.

15. Short-term memory binding: validity as a cognitive biomarker for Alzheimer's disease across cultures and nations. Dr Juan Felipe Cardona Londoño. Neuroscience Group, University of Valle, Cali, Colombia.

16. Memory and learning in Sporadic Alzheimer’s disease and amnesia. Dr. Simona Luzzi. Clinical Neurology of the Polytechnic University of Marche in Ancona, Italy.

17. Memory and learning in healthy ageing and Alzheimer’s disease. Professor Efrain Amaya. DNEUROPSY Group, Surcolombiana University, Huila, Colombia.

18. Studying the preclinical phase of AD. Professor Francisco Lopera, Neuroscience Group, University of Antioquia, Colombia. Memory and learning in familial (genetic) Alzheimer’s disease.